Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Brain edema: pathogenesis and therapy

L Schilling¹, M Wahl

¹University of Heidelberg, Faculty of Clinical Medicine, Department of Neurosurgery, Mannheim, Germany.

Kidney International. Supplement

|June 1, 1997

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Co-occurrence of native and invasive macroalgae might be facilitated under global warming.

The Science of the total environment·2023

Same author

Induction of a NOTCH3 Lehman syndrome mutation in osteocytes causes osteopenia in male C57BL/6J mice.

Bone·2022

Same author

Role of nuclear factor of activated T cells in chondrogenesis osteogenesis and osteochondroma formation.

Journal of endocrinological investigation·2022

Same author

Biotic and abiotic drivers affect parasite richness, prevalence and abundance in <i>Mytilus galloprovincialis</i> along the Northern Adriatic Sea.

Parasitology·2021

Same author

Comparative transcriptome analysis of inner blood-retinal barrier and blood-brain barrier in rats.

Scientific reports·2021

Same author

Parent and Teacher Perspectives on Factors Decreasing Participation in School-Based Vision Programs.

Ophthalmic epidemiology·2020

Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011

Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011

Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011

Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011

Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011

Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011

See all related articles

Bradykinin is identified as a key mediator of vasogenic brain edema by fulfilling five critical criteria. While other autacoids are implicated, bradykinin shows the most robust evidence for its role in blood-brain barrier disruption.

Area of Science:

Neuroscience
Pathophysiology
Pharmacology

Background:

The blood-brain barrier (BBB) regulates substance passage between blood and brain.
Pathological conditions like trauma and ischemia can increase BBB permeability.
This increased permeability allows plasma constituents into brain tissue, causing vasogenic brain edema.

Purpose of the Study:

To identify autacoids that mediate vasogenic brain edema.
To evaluate potential mediator candidates based on five established criteria.
To assess the role of bradykinin in blood-brain barrier dysfunction.

Main Methods:

Evaluation of autacoids based on five criteria: permeability enhancement, vasodilation, edema induction, increased pathological concentration, and inhibition of edema.

Related Experiment Videos

Comparison of evidence for various autacoids, including histamine, arachidonic acid, nitric oxide, and bradykinin.

Review of experimental data supporting the role of autacoids in brain edema.

Main Results:

Bradykinin meets all five criteria for mediating vasogenic brain edema.
Histamine, arachidonic acid, and nitric oxide show less conclusive evidence as mediators.
Experimental data support the concept of autacoids mediating brain edema.

Conclusions:

Bradykinin is the strongest candidate for mediating vasogenic brain edema.
Current clinical treatments for vasogenic brain edema are symptomatic, focusing on intracranial pressure.
Further research is needed to translate the understanding of autacoid mediators into clinical practice.